Skip to content
10-Q

Quarterly Report

Advanced BioMedical Technologies, Inc.

0001493152-20-011580

← back to feed
Filed
Jun 22, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Jun 22, 2020 69.97M sh
Cash And Equivalents Q2 2020 · Apr 30, 2020 $10.64K
Cash And Equivalents Q2 2020 · Oct 31, 2019 $5.59K
Current Liabilities Q2 2020 · Apr 30, 2020 $6.98M
Current Liabilities Q2 2020 · Oct 31, 2019 $6.7M
Current Assets Q2 2020 · Apr 30, 2020 $111.55K
Current Assets Q2 2020 · Oct 31, 2019 $119.47K
Total Assets Q2 2020 · Apr 30, 2020 $276.36K
Total Assets Q2 2020 · Oct 31, 2019 $218.5K
Shares Diluted Q2 2020 · Apr 30, 2019 69.62M sh
Shares Diluted Q2 2020 · Apr 30, 2019 69.62M sh
Capex Q2 2020 · Apr 30, 2019 $12.1K
Operating Cash Flow Q2 2020 · Apr 30, 2019 −$428.04K
Stockholders Equity Q2 2020 · Apr 30, 2019 −$6.28M
Stockholders Equity Q2 2020 · Jan 31, 2019 −$6.08M
Stockholders Equity Q2 2020 · Oct 31, 2018 −$5.62M
Sga Expense Q2 2020 · Apr 30, 2019 $127.47K
Sga Expense Q2 2020 · Apr 30, 2019 $275.4K
Rd Expense Q2 2020 · Apr 30, 2019 $16.04K
Rd Expense Q2 2020 · Apr 30, 2019 $33.02K
Net Income Q2 2020 · Apr 30, 2019 −$235.68K
Net Income Q2 2020 · Apr 30, 2019 −$488.2K
Net Income Q2 2020 · Jan 31, 2019 −$252.52K
Operating Income Q2 2020 · Apr 30, 2019 −$148.53K
Operating Income Q2 2020 · Apr 30, 2019 −$318.44K